{"schema_version":"1","generated_at":"2026-11-10T11:34:34.216Z","data_as_of":null,"url":"https://www.findmykol.com/kol/albert-assad","json_url":"https://www.findmykol.com/kol/albert-assad/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"albert-assad","name":"Albert Assad","credential":"MD","specialty":"Surgery","specialty_raw":"Surgery","therapeutic_area":"Surgery","therapeutic_areas":["Surgery"],"institution":"Incyte","institution_url":"https://www.findmykol.com/institution/incyte","city":"New Brunswick","state":"NJ","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1053419093","orcid":"0009-0008-3705-0585","openalex":"A5109421874"},"summary":"Albert Assad is a Surgery physician affiliated with Incyte. OpenAlex indexes 57 publications with 1,197 citations (h-index 15); ClinicalTrials.gov lists 10 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Surgery"]},"scholarship":{"works_count":57,"cited_by_count":1197,"h_index":15,"source":"works"},"trials":{"count":10,"shown":3,"withheld":7,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06585774","title":"A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease","phase":"PHASE3","status":"RECRUITING","role":"Overall official","sponsor":"Incyte Corporation","source_url":"https://clinicaltrials.gov/study/NCT06585774","trial_url":"https://www.findmykol.com/trial/NCT06585774"},{"nct":"NCT04551066","title":"To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)","phase":"PHASE3","status":"TERMINATED","role":"Overall official","sponsor":"Incyte Corporation","source_url":"https://clinicaltrials.gov/study/NCT04551066","trial_url":"https://www.findmykol.com/trial/NCT04551066"},{"nct":"NCT04551053","title":"To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)","phase":"PHASE3","status":"TERMINATED","role":"Overall official","sponsor":"Incyte Corporation","source_url":"https://clinicaltrials.gov/study/NCT04551053","trial_url":"https://www.findmykol.com/trial/NCT04551053"}],"source":"trials"},"similar":[{"name":"Gerard Kennealey","slug":"gerard-kennealey","institution":"Incyte","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gerard-kennealey","json_url":"https://www.findmykol.com/kol/gerard-kennealey/profile.json"},{"name":"Thomas Hultsch","slug":"thomas-hultsch","institution":"Incyte","url":"https://www.findmykol.com/kol/thomas-hultsch","json_url":"https://www.findmykol.com/kol/thomas-hultsch/profile.json"},{"name":"Evan Braunstein","slug":"evan-braunstein","institution":"Incyte","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/evan-braunstein","json_url":"https://www.findmykol.com/kol/evan-braunstein/profile.json"},{"name":"Kang Sun","slug":"kang-sun-us","institution":"Incyte","url":"https://www.findmykol.com/kol/kang-sun-us","json_url":"https://www.findmykol.com/kol/kang-sun-us/profile.json"},{"name":"Yao Xiao","slug":"yao-xiao","institution":"Brigham and Women's Hospital","specialty":"Surgery","url":"https://www.findmykol.com/kol/yao-xiao","json_url":"https://www.findmykol.com/kol/yao-xiao/profile.json"},{"name":"Thomas Tsai","slug":"thomas-tsai","specialty":"Surgery","url":"https://www.findmykol.com/kol/thomas-tsai","json_url":"https://www.findmykol.com/kol/thomas-tsai/profile.json"},{"name":"Peter Wang","slug":"peter-wang","specialty":"Surgery","url":"https://www.findmykol.com/kol/peter-wang","json_url":"https://www.findmykol.com/kol/peter-wang/profile.json"},{"name":"John Francis","slug":"john-francis","specialty":"Surgery","url":"https://www.findmykol.com/kol/john-francis","json_url":"https://www.findmykol.com/kol/john-francis/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":7}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"}},"methodology_url":"https://www.findmykol.com/about#methodology"}